Quest Diagnostics Incorporated

NYSE:DGX Stok Raporu

Piyasa değeri: US$17.2b

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Quest Diagnostics Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Quest Diagnostics şirketinin toplam hissedar öz sermayesi $6.7B ve toplam borcu $4.4B olup, bu da borç-öz sermaye oranını 65.4% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla $13.9B ve $7.1B dir. Quest Diagnostics 'in FAVÖK'ü $1.3B faiz karşılama oranı 8 dur. Şirketin $271.0M tutarında nakit ve kısa vadeli yatırımları bulunmaktadır.

Anahtar bilgiler

65.4%

Borç/özkaynak oranı

US$4.41b

Borç

Faiz karşılama oranı8x
NakitUS$271.00m
EşitlikUS$6.74b
Toplam yükümlülüklerUS$7.15b
Toplam varlıklarUS$13.88b

Son finansal sağlık güncellemeleri

Recent updates

These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Aug 30
These 4 Measures Indicate That Quest Diagnostics (NYSE:DGX) Is Using Debt Reasonably Well

Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Aug 12
Should You Think About Buying Quest Diagnostics Incorporated (NYSE:DGX) Now?

Quest Diagnostics: Beat Down After Beating Q2 Estimates

Jul 28

The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Jul 12
The Price Is Right For Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics: On A Quest For Growth

Jul 12

Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

May 14
Quest Diagnostics (NYSE:DGX) Hasn't Managed To Accelerate Its Returns

Quest Diagnostics: Let's Keep Waiting

May 08

Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

Apr 26
Results: Quest Diagnostics Incorporated Beat Earnings Expectations And Analysts Now Have New Forecasts

We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Apr 23
We Think Quest Diagnostics (NYSE:DGX) Can Stay On Top Of Its Debt

Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Apr 02
Unpleasant Surprises Could Be In Store For Quest Diagnostics Incorporated's (NYSE:DGX) Shares

Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Mar 15
Quest Diagnostics (NYSE:DGX) Is Paying Out A Larger Dividend Than Last Year

Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Feb 06
Quest Diagnostics (NYSE:DGX) Has Announced That It Will Be Increasing Its Dividend To $0.75

Quest Diagnostics: Post-COVID Normalization Pretty Much Done

Feb 05

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 11
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Dec 24
Why We're Not Concerned About Quest Diagnostics Incorporated's (NYSE:DGX) Share Price

Quest Diagnostics: Market Overreaction Creates Investment Opportunity

Dec 08

Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Dec 06
Is There Now An Opportunity In Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Nov 18
Quest Diagnostics' (NYSE:DGX) Returns Have Hit A Wall

Quest Diagnostics: Moving Past Covid

Oct 25

Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

Sep 25
Here's Why Quest Diagnostics (NYSE:DGX) Can Manage Its Debt Responsibly

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Sep 04
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Quest Diagnostics: Q2 Earnings Reveal Promising Growth Trends Despite Dwindling COVID Testing Revenues

Aug 15

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Aug 13
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Jul 11
Quest Diagnostics Incorporated (NYSE:DGX) Shares Could Be 46% Below Their Intrinsic Value Estimate

Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Jun 09
Is Quest Diagnostics (NYSE:DGX) A Risky Investment?

Quest Diagnostics: Healthier Diagnosis

May 30

Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

May 24
Is It Time To Consider Buying Quest Diagnostics Incorporated (NYSE:DGX)?

Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

May 09
Quest Diagnostics (NYSE:DGX) Has More To Do To Multiply In Value Going Forward

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

Mar 22
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 24% Undervalued

What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Feb 19
What Does Quest Diagnostics Incorporated's (NYSE:DGX) Share Price Indicate?

Why Quest Diagnostics Isn't A 'Buy', My Oh My

Feb 14

Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Feb 05
Quest Diagnostics' (NYSE:DGX) Upcoming Dividend Will Be Larger Than Last Year's

Quest Diagnostics Q4 2022 Earnings Preview

Feb 01

Quest Diagnostics' unit Pack Health to expand Alabama facility

Jan 17

Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Jan 17
Quest Diagnostics (NYSE:DGX) Seems To Use Debt Quite Sensibly

Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)

Jan 03
Returns On Capital Are Showing Encouraging Signs At Quest Diagnostics (NYSE:DGX)

An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued

Dec 04
An Intrinsic Calculation For Quest Diagnostics Incorporated (NYSE:DGX) Suggests It's 46% Undervalued

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: DGX 'nin kısa vadeli varlıkları ( $2.0B ) kısa vadeli yükümlülüklerini ( $2.0B ) aşıyor.

Uzun Vadeli Yükümlülükler: DGX 'un kısa vadeli varlıkları ( $2.0B ) uzun vadeli yükümlülüklerini ( $5.1B ) karşılamamaktadır.


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: DGX 'nin net borç/öz sermaye oranı ( 61.4% ) yüksek olarak değerlendiriliyor.

Borcun Azaltılması: DGX 'nin borç/öz sermaye oranı son 5 yılda 71.2% seviyesinden 65.4% seviyesine düştü.

Borç Kapsamı: DGX 'nin borcu işletme nakit akışı ( 28.3% ) tarafından iyi bir şekilde karşılanmaktadır.

Faiz Kapsamı: DGX 'in borcuna ilişkin faiz ödemeleri EBIT ( 8 x kapsam) tarafından iyi bir şekilde karşılanmaktadır.


Bilanço


Sağlıklı şirketleri keşfedin